Skip to main content
Equibles

Snowden Capital Advisors LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1903055 New York, NY
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,703,511
-$509,329 QoQ
Shares Held
2,732
-4.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#547
of 1,329 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Snowden Capital Advisors LLC holds $12,669,600 across 24 Biotechnology names. REGN ranks #2 (13.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,230 $2,101,167
2 REGN
Regeneron Pharmaceuticals, Inc.
This page 		2,732 $1,703,511
3 ARGX
Argenx SE
 1,311 $1,216,306
4 MDGL
Madrigal Pharmaceuticals, Inc.
 1,952 $1,048,126
5 INSM
INSMED Inc
 7,262 $774,274
6 IDYA
IDEAYA Biosciences, Inc.
 17,281 $644,062
7 QURE
uniQure N.V.
 10,874 $500,856
8 ASND
Ascendis Pharma A/S
 1,583 $422,217

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,703,511 2,732
2026-03-31 $2,212,840 2,864
2025-12-31 $2,071,699 2,684
2025-09-30 $1,284,224 2,284
2025-06-30 $901,950 1,718
2025-03-31 $1,224,698 1,931
2024-12-31 $1,151,837 1,617
2024-09-30 $1,586,321 1,509
2024-06-30 $1,774,138 1,688
2024-03-31 $1,771,944 1,841
2023-12-31 $1,020,572 1,162
2023-09-30 $926,652 1,126
2023-06-30 $861,529 1,199
2023-03-31 $925,200 1,126
2022-12-31 $984,112 1,364
2022-09-30 $1,004,372 1,458
2022-06-30 $960,586 1,625
2022-03-31 $1,350,744 1,934
2021-12-31 $479,323 759
2021-09-30 $1,095,375 1,810
2021-06-30 $1,004,813 1,799
2021-03-31 $702,612 1,485
2020-12-31 $355,085 735
2020-09-30 $287,167 513
2020-06-30 $314,319 504
2020-03-31 $256,840 526